Gestational diabetes & diabetes in pregnancy

Various screening and diagnosis approaches for gestational diabetes mellitus and adverse pregnancy outcomes: a secondary analysis of a randomized non-inferiority field trial

BMJ Open Diabetes Res CarePublished Secondary analysis of a randomised community non-inferiority field trial

Authors' conclusion

We conclude that screening approaches for GDM reduced the risk of adverse pregnancy outcomes to the same or near the same risk level of healthy pregnant women, except for the risk of NICU admission that increased significantly in groups diagnosed with GDM compared with healthy pregnant women. Individuals with slight increase in FPG (92-100 mg/dL) at first trimester, who were diagnosed as GDM, had an even increased risk of macrosomia in comparison to those group of women with FPG 92-100 mg/dL in the first trimester, who were not diagnosed with GDM, and developed GDM in second trimester

Study context

Population
Pregnant women participating in the GULF Study in Iran5 screening protocols
Participants
35,430 women
Comparison
Gestational diabetes mellitus (GDM) screening/diagnosis categories by first-trimester fasting plasma glucose (FPG) and second-trimester one-step or two-step screening
Primary endpoint
Major adverse maternal and neonatal outcomes
Methodological detailsGULF Study, randomized, five prespecified GDM screening protocols
  • GULF Study
  • Randomized
  • Five prespecified GDM screening protocols

Primary result

As reported in the abstract

GroupValuePrimary caesarean section
Group 19.8%21.0%
Group 27.8%19.8%
Group 35.4%18.6%
Group 46.6%21.5%
Group 58.3%24.0%
Group 65.4%20.0%

Value

Group 19.8%
Group 27.8%
Group 35.4%
Group 46.6%
Group 58.3%
Group 65.4%

Primary caesarean section

Group 121.0%
Group 219.8%
Group 318.6%
Group 421.5%
Group 524.0%
Group 620.0%

Original publication

Various screening and diagnosis approaches for gestational diabetes mellitus and adverse pregnancy outcomes: a secondary analysis of a randomized non-inferiority field trial. BMJ Open Diabetes Res Care. Published 12 December 2023. doi:10.1136/bmjdrc-2023-003510

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.